The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neurovascular Intervention Guidewire Market Research Report 2025
Synopsis
Neurovascular Intervention Guidewires are thin, flexible wire used in neurointerventional procedures to access and navigate through blood vessels in the brain and spinal cord. The wire is inserted through a catheter and carefully guided to the target site, serving as a pathway for placing other devices such as stents or coils.
The global Neurovascular Intervention Guidewire market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Neurovascular Intervention Guidewire is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neurovascular Intervention Guidewire is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Neurovascular Intervention Guidewire include Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation and B. Braun Melsungen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neurovascular Intervention Guidewire, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Intervention Guidewire.
Report Scope
The Neurovascular Intervention Guidewire market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurovascular Intervention Guidewire market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurovascular Intervention Guidewire manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Terumo Medical
Medtronic
Abbott Laboratories
Stryker
Penumbra
Merit Medical Systems
Boston Scientific
Integer Holdings Corporation
B. Braun Melsungen
Teleflex
TE Connectivity
Johnson & Johnson
Smiths Group
Asahi Intecc
Cordis Corporation
Cook Medical
Lepu Meidcal
Scientia Vascular
FMD Co., Ltd.
Sino Medical Sciences Technology Inc.
MicroPort NeuroTech
Shanghai HeartCare Medical Technology Corporation Limited
Peijia Medical
Zhejiang Medical Devices Co., Ltd. Owned By Year
Shanghai Yingtai Medical Equipment
Beijing Taijieweiye Technology
Shunmei MEDICAL
MicroVenti
Artiria Medical
Segment by Type
Solid Guide Wire
Wrapped Guide Wire
Segment by Application
Hospitals
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurovascular Intervention Guidewire manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurovascular Intervention Guidewire in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Neurovascular Intervention Guidewires are thin, flexible wire used in neurointerventional procedures to access and navigate through blood vessels in the brain and spinal cord. The wire is inserted through a catheter and carefully guided to the target site, serving as a pathway for placing other devices such as stents or coils.
The global Neurovascular Intervention Guidewire market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Neurovascular Intervention Guidewire is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neurovascular Intervention Guidewire is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Neurovascular Intervention Guidewire include Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation and B. Braun Melsungen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neurovascular Intervention Guidewire, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Intervention Guidewire.
Report Scope
The Neurovascular Intervention Guidewire market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurovascular Intervention Guidewire market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurovascular Intervention Guidewire manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Terumo Medical
Medtronic
Abbott Laboratories
Stryker
Penumbra
Merit Medical Systems
Boston Scientific
Integer Holdings Corporation
B. Braun Melsungen
Teleflex
TE Connectivity
Johnson & Johnson
Smiths Group
Asahi Intecc
Cordis Corporation
Cook Medical
Lepu Meidcal
Scientia Vascular
FMD Co., Ltd.
Sino Medical Sciences Technology Inc.
MicroPort NeuroTech
Shanghai HeartCare Medical Technology Corporation Limited
Peijia Medical
Zhejiang Medical Devices Co., Ltd. Owned By Year
Shanghai Yingtai Medical Equipment
Beijing Taijieweiye Technology
Shunmei MEDICAL
MicroVenti
Artiria Medical
Segment by Type
Solid Guide Wire
Wrapped Guide Wire
Segment by Application
Hospitals
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurovascular Intervention Guidewire manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurovascular Intervention Guidewire in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Neurovascular Intervention Guidewire Market Overview
1.1 Product Overview and Scope of Neurovascular Intervention Guidewire
1.2 Neurovascular Intervention Guidewire Segment by Type
1.2.1 Global Neurovascular Intervention Guidewire Market Value Comparison by Type (2024-2030)
1.2.2 Solid Guide Wire
1.2.3 Wrapped Guide Wire
1.3 Neurovascular Intervention Guidewire Segment by Application
1.3.1 Global Neurovascular Intervention Guidewire Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Global Neurovascular Intervention Guidewire Market Size Estimates and Forecasts
1.4.1 Global Neurovascular Intervention Guidewire Revenue 2019-2030
1.4.2 Global Neurovascular Intervention Guidewire Sales 2019-2030
1.4.3 Global Neurovascular Intervention Guidewire Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurovascular Intervention Guidewire Market Competition by Manufacturers
2.1 Global Neurovascular Intervention Guidewire Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurovascular Intervention Guidewire Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurovascular Intervention Guidewire Average Price by Manufacturers (2019-2024)
2.4 Global Neurovascular Intervention Guidewire Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurovascular Intervention Guidewire, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurovascular Intervention Guidewire, Product Type & Application
2.7 Neurovascular Intervention Guidewire Market Competitive Situation and Trends
2.7.1 Neurovascular Intervention Guidewire Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurovascular Intervention Guidewire Players Market Share by Revenue
2.7.3 Global Neurovascular Intervention Guidewire Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurovascular Intervention Guidewire Retrospective Market Scenario by Region
3.1 Global Neurovascular Intervention Guidewire Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurovascular Intervention Guidewire Global Neurovascular Intervention Guidewire Sales by Region: 2019-2030
3.2.1 Global Neurovascular Intervention Guidewire Sales by Region: 2019-2024
3.2.2 Global Neurovascular Intervention Guidewire Sales by Region: 2025-2030
3.3 Global Neurovascular Intervention Guidewire Global Neurovascular Intervention Guidewire Revenue by Region: 2019-2030
3.3.1 Global Neurovascular Intervention Guidewire Revenue by Region: 2019-2024
3.3.2 Global Neurovascular Intervention Guidewire Revenue by Region: 2025-2030
3.4 North America Neurovascular Intervention Guidewire Market Facts & Figures by Country
3.4.1 North America Neurovascular Intervention Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurovascular Intervention Guidewire Sales by Country (2019-2030)
3.4.3 North America Neurovascular Intervention Guidewire Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurovascular Intervention Guidewire Market Facts & Figures by Country
3.5.1 Europe Neurovascular Intervention Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurovascular Intervention Guidewire Sales by Country (2019-2030)
3.5.3 Europe Neurovascular Intervention Guidewire Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurovascular Intervention Guidewire Market Facts & Figures by Country
3.6.1 Asia Pacific Neurovascular Intervention Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurovascular Intervention Guidewire Sales by Country (2019-2030)
3.6.3 Asia Pacific Neurovascular Intervention Guidewire Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurovascular Intervention Guidewire Market Facts & Figures by Country
3.7.1 Latin America Neurovascular Intervention Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurovascular Intervention Guidewire Sales by Country (2019-2030)
3.7.3 Latin America Neurovascular Intervention Guidewire Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurovascular Intervention Guidewire Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurovascular Intervention Guidewire Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurovascular Intervention Guidewire Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurovascular Intervention Guidewire Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurovascular Intervention Guidewire Sales by Type (2019-2030)
4.1.1 Global Neurovascular Intervention Guidewire Sales by Type (2019-2024)
4.1.2 Global Neurovascular Intervention Guidewire Sales by Type (2025-2030)
4.1.3 Global Neurovascular Intervention Guidewire Sales Market Share by Type (2019-2030)
4.2 Global Neurovascular Intervention Guidewire Revenue by Type (2019-2030)
4.2.1 Global Neurovascular Intervention Guidewire Revenue by Type (2019-2024)
4.2.2 Global Neurovascular Intervention Guidewire Revenue by Type (2025-2030)
4.2.3 Global Neurovascular Intervention Guidewire Revenue Market Share by Type (2019-2030)
4.3 Global Neurovascular Intervention Guidewire Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurovascular Intervention Guidewire Sales by Application (2019-2030)
5.1.1 Global Neurovascular Intervention Guidewire Sales by Application (2019-2024)
5.1.2 Global Neurovascular Intervention Guidewire Sales by Application (2025-2030)
5.1.3 Global Neurovascular Intervention Guidewire Sales Market Share by Application (2019-2030)
5.2 Global Neurovascular Intervention Guidewire Revenue by Application (2019-2030)
5.2.1 Global Neurovascular Intervention Guidewire Revenue by Application (2019-2024)
5.2.2 Global Neurovascular Intervention Guidewire Revenue by Application (2025-2030)
5.2.3 Global Neurovascular Intervention Guidewire Revenue Market Share by Application (2019-2030)
5.3 Global Neurovascular Intervention Guidewire Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Terumo Medical
6.1.1 Terumo Medical Corporation Information
6.1.2 Terumo Medical Description and Business Overview
6.1.3 Terumo Medical Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Terumo Medical Neurovascular Intervention Guidewire Product Portfolio
6.1.5 Terumo Medical Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Neurovascular Intervention Guidewire Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Neurovascular Intervention Guidewire Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Corporation Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Stryker Neurovascular Intervention Guidewire Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 Penumbra
6.5.1 Penumbra Corporation Information
6.5.2 Penumbra Description and Business Overview
6.5.3 Penumbra Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Penumbra Neurovascular Intervention Guidewire Product Portfolio
6.5.5 Penumbra Recent Developments/Updates
6.6 Merit Medical Systems
6.6.1 Merit Medical Systems Corporation Information
6.6.2 Merit Medical Systems Description and Business Overview
6.6.3 Merit Medical Systems Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merit Medical Systems Neurovascular Intervention Guidewire Product Portfolio
6.6.5 Merit Medical Systems Recent Developments/Updates
6.7 Boston Scientific
6.6.1 Boston Scientific Corporation Information
6.6.2 Boston Scientific Description and Business Overview
6.6.3 Boston Scientific Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Neurovascular Intervention Guidewire Product Portfolio
6.7.5 Boston Scientific Recent Developments/Updates
6.8 Integer Holdings Corporation
6.8.1 Integer Holdings Corporation Corporation Information
6.8.2 Integer Holdings Corporation Description and Business Overview
6.8.3 Integer Holdings Corporation Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Integer Holdings Corporation Neurovascular Intervention Guidewire Product Portfolio
6.8.5 Integer Holdings Corporation Recent Developments/Updates
6.9 B. Braun Melsungen
6.9.1 B. Braun Melsungen Corporation Information
6.9.2 B. Braun Melsungen Description and Business Overview
6.9.3 B. Braun Melsungen Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.9.4 B. Braun Melsungen Neurovascular Intervention Guidewire Product Portfolio
6.9.5 B. Braun Melsungen Recent Developments/Updates
6.10 Teleflex
6.10.1 Teleflex Corporation Information
6.10.2 Teleflex Description and Business Overview
6.10.3 Teleflex Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teleflex Neurovascular Intervention Guidewire Product Portfolio
6.10.5 Teleflex Recent Developments/Updates
6.11 TE Connectivity
6.11.1 TE Connectivity Corporation Information
6.11.2 TE Connectivity Neurovascular Intervention Guidewire Description and Business Overview
6.11.3 TE Connectivity Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.11.4 TE Connectivity Neurovascular Intervention Guidewire Product Portfolio
6.11.5 TE Connectivity Recent Developments/Updates
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Corporation Information
6.12.2 Johnson & Johnson Neurovascular Intervention Guidewire Description and Business Overview
6.12.3 Johnson & Johnson Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Johnson & Johnson Neurovascular Intervention Guidewire Product Portfolio
6.12.5 Johnson & Johnson Recent Developments/Updates
6.13 Smiths Group
6.13.1 Smiths Group Corporation Information
6.13.2 Smiths Group Neurovascular Intervention Guidewire Description and Business Overview
6.13.3 Smiths Group Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Smiths Group Neurovascular Intervention Guidewire Product Portfolio
6.13.5 Smiths Group Recent Developments/Updates
6.14 Asahi Intecc
6.14.1 Asahi Intecc Corporation Information
6.14.2 Asahi Intecc Neurovascular Intervention Guidewire Description and Business Overview
6.14.3 Asahi Intecc Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Asahi Intecc Neurovascular Intervention Guidewire Product Portfolio
6.14.5 Asahi Intecc Recent Developments/Updates
6.15 Cordis Corporation
6.15.1 Cordis Corporation Corporation Information
6.15.2 Cordis Corporation Neurovascular Intervention Guidewire Description and Business Overview
6.15.3 Cordis Corporation Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cordis Corporation Neurovascular Intervention Guidewire Product Portfolio
6.15.5 Cordis Corporation Recent Developments/Updates
6.16 Cook Medical
6.16.1 Cook Medical Corporation Information
6.16.2 Cook Medical Neurovascular Intervention Guidewire Description and Business Overview
6.16.3 Cook Medical Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Cook Medical Neurovascular Intervention Guidewire Product Portfolio
6.16.5 Cook Medical Recent Developments/Updates
6.17 Lepu Meidcal
6.17.1 Lepu Meidcal Corporation Information
6.17.2 Lepu Meidcal Neurovascular Intervention Guidewire Description and Business Overview
6.17.3 Lepu Meidcal Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Lepu Meidcal Neurovascular Intervention Guidewire Product Portfolio
6.17.5 Lepu Meidcal Recent Developments/Updates
6.18 Scientia Vascular
6.18.1 Scientia Vascular Corporation Information
6.18.2 Scientia Vascular Neurovascular Intervention Guidewire Description and Business Overview
6.18.3 Scientia Vascular Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Scientia Vascular Neurovascular Intervention Guidewire Product Portfolio
6.18.5 Scientia Vascular Recent Developments/Updates
6.19 FMD Co., Ltd.
6.19.1 FMD Co., Ltd. Corporation Information
6.19.2 FMD Co., Ltd. Neurovascular Intervention Guidewire Description and Business Overview
6.19.3 FMD Co., Ltd. Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.19.4 FMD Co., Ltd. Neurovascular Intervention Guidewire Product Portfolio
6.19.5 FMD Co., Ltd. Recent Developments/Updates
6.20 Sino Medical Sciences Technology Inc.
6.20.1 Sino Medical Sciences Technology Inc. Corporation Information
6.20.2 Sino Medical Sciences Technology Inc. Neurovascular Intervention Guidewire Description and Business Overview
6.20.3 Sino Medical Sciences Technology Inc. Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sino Medical Sciences Technology Inc. Neurovascular Intervention Guidewire Product Portfolio
6.20.5 Sino Medical Sciences Technology Inc. Recent Developments/Updates
6.21 MicroPort NeuroTech
6.21.1 MicroPort NeuroTech Corporation Information
6.21.2 MicroPort NeuroTech Neurovascular Intervention Guidewire Description and Business Overview
6.21.3 MicroPort NeuroTech Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.21.4 MicroPort NeuroTech Neurovascular Intervention Guidewire Product Portfolio
6.21.5 MicroPort NeuroTech Recent Developments/Updates
6.22 Shanghai HeartCare Medical Technology Corporation Limited
6.22.1 Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
6.22.2 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Intervention Guidewire Description and Business Overview
6.22.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Intervention Guidewire Product Portfolio
6.22.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
6.23 Peijia Medical
6.23.1 Peijia Medical Corporation Information
6.23.2 Peijia Medical Neurovascular Intervention Guidewire Description and Business Overview
6.23.3 Peijia Medical Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Peijia Medical Neurovascular Intervention Guidewire Product Portfolio
6.23.5 Peijia Medical Recent Developments/Updates
6.24 Zhejiang Medical Devices Co., Ltd. Owned By Year
6.24.1 Zhejiang Medical Devices Co., Ltd. Owned By Year Corporation Information
6.24.2 Zhejiang Medical Devices Co., Ltd. Owned By Year Neurovascular Intervention Guidewire Description and Business Overview
6.24.3 Zhejiang Medical Devices Co., Ltd. Owned By Year Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Zhejiang Medical Devices Co., Ltd. Owned By Year Neurovascular Intervention Guidewire Product Portfolio
6.24.5 Zhejiang Medical Devices Co., Ltd. Owned By Year Recent Developments/Updates
6.25 Shanghai Yingtai Medical Equipment
6.25.1 Shanghai Yingtai Medical Equipment Corporation Information
6.25.2 Shanghai Yingtai Medical Equipment Neurovascular Intervention Guidewire Description and Business Overview
6.25.3 Shanghai Yingtai Medical Equipment Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Shanghai Yingtai Medical Equipment Neurovascular Intervention Guidewire Product Portfolio
6.25.5 Shanghai Yingtai Medical Equipment Recent Developments/Updates
6.26 Beijing Taijieweiye Technology
6.26.1 Beijing Taijieweiye Technology Corporation Information
6.26.2 Beijing Taijieweiye Technology Neurovascular Intervention Guidewire Description and Business Overview
6.26.3 Beijing Taijieweiye Technology Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Beijing Taijieweiye Technology Neurovascular Intervention Guidewire Product Portfolio
6.26.5 Beijing Taijieweiye Technology Recent Developments/Updates
6.27 Shunmei MEDICAL
6.27.1 Shunmei MEDICAL Corporation Information
6.27.2 Shunmei MEDICAL Neurovascular Intervention Guidewire Description and Business Overview
6.27.3 Shunmei MEDICAL Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Shunmei MEDICAL Neurovascular Intervention Guidewire Product Portfolio
6.27.5 Shunmei MEDICAL Recent Developments/Updates
6.28 MicroVenti
6.28.1 MicroVenti Corporation Information
6.28.2 MicroVenti Neurovascular Intervention Guidewire Description and Business Overview
6.28.3 MicroVenti Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.28.4 MicroVenti Neurovascular Intervention Guidewire Product Portfolio
6.28.5 MicroVenti Recent Developments/Updates
6.29 Artiria Medical
6.29.1 Artiria Medical Corporation Information
6.29.2 Artiria Medical Neurovascular Intervention Guidewire Description and Business Overview
6.29.3 Artiria Medical Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2019-2024)
6.29.4 Artiria Medical Neurovascular Intervention Guidewire Product Portfolio
6.29.5 Artiria Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurovascular Intervention Guidewire Industry Chain Analysis
7.2 Neurovascular Intervention Guidewire Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurovascular Intervention Guidewire Production Mode & Process
7.4 Neurovascular Intervention Guidewire Sales and Marketing
7.4.1 Neurovascular Intervention Guidewire Sales Channels
7.4.2 Neurovascular Intervention Guidewire Distributors
7.5 Neurovascular Intervention Guidewire Customers
8 Neurovascular Intervention Guidewire Market Dynamics
8.1 Neurovascular Intervention Guidewire Industry Trends
8.2 Neurovascular Intervention Guidewire Market Drivers
8.3 Neurovascular Intervention Guidewire Market Challenges
8.4 Neurovascular Intervention Guidewire Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
